As an important vascular interventional medical device, special balloons can better focus the inflation and extrusion stress of the balloon by attaching metal or other material cutting pieces to the working surface of conventional balloon dilation catheters. This not only effectively dilates narrow blood vessels but also reduces risks such as residual stenosis and vascular dissection. China's R&D strength in special balloons has rapidly increased, and the speed of product launch has accelerated in recent years, promoting the process of domestic substitution for imports. As of January 2024, among the more than 30 special balloon products approved for marketing by the NMPA, domestic special balloon products account for about 50%, including cutting balloons, directional scoring balloons, guide wire scoring balloons, spiculated balloons, mastoid balloons, peripheral restraint balloons, scoring drug-coated balloons, etc., covering the fields of coronary and peripheral vascular interventional treatment. Special balloons have gradually developed from adjuvant therapy to primary treatment methods in multiple indications due to their excellent capabilities, providing better options for more patients with vascular stenosis.
On March 5th, Frost & Sullivan (hereinafter referred to as 'Frost & Sullivan') officially released the 'Blue Book on the Current Situation and Development Trends of Vascular Interventional Special Balloons' (hereinafter referred to as the 'Blue Book'). The report analyzes the current situation of the vascular interventional special balloon industry, comprehensively elaborating from dimensions such as technological development, application fields, marketed products, and capital enthusiasm. It tracks the development context of the industry and technology, explores the huge potential for industry development, and analyzes market development trends, aiming to provide a reference for participants and stakeholders in the field of vascular interventional special balloons.
